IPOs
– VBL is developing drugs for the treatment of cancer and inflammatory diseases. On Friday, VBL Therapeutics Ltd. (formerly Vascular Biogenics) published a draft prospectus...
Hi, what are you looking for?
– VBL is developing drugs for the treatment of cancer and inflammatory diseases. On Friday, VBL Therapeutics Ltd. (formerly Vascular Biogenics) published a draft prospectus...
– Philips Israel chief Guido Pardo Roques: The incubator will also do medical devices. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and Philips...
– Executives in Israel for the MIXiii conference tell “Globes” about the future of medicine. – – 2014 is positioned to go down...
– The company has two products in clinical trials for the treatment of Parkinson’s. – – Transdermal drug delivery system developer Neuroderm Ltd. has filed a...
– Novartis had signed an MOU to acquire the stem cell treatment company for up to $600 million. – Elbit Medical Technologies Ltd. (TASE:EMTC)...
– – Bonus Biogroup Ltd. (TASE: BONS), which has developed a method for producing bone grafts from stem cells, has begun a clinical trial of jawbone...
– Natali Seculife is in advanced talks to merge its international operations with China’s Sanpower Group at a value of $70 million. – –...
– Teva is resuming investments in Israeli startups. Sources inform ”Globes” that Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and Philips Healthcare jointly bid in the Office...
– 206 start-ups have been founded in the past six years. – – In the six years since nanotechnology was declared a national research...
– Sales of Protalix’s Gaucher’s disease drug to Pfizer totaled $4.4 million in 2013. – – Protalix Biotherapeutics Inc. (NYSE MKT:PLX; TASE: PLX) is not yet seeing...